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Abstract Rett syndrome (RTT) is a severe neurodevelopmental disorder affecting almost
exclusively females. The Hanefeld variant, or early-onset seizure variant, has been
associated with mutations in CDKL5 gene.
Aims In recent years more than 60 patients with mutations in the CDKL5 gene have
been described in the literature, but the cardiorespiratory phenotype has not been
reported. Our aim is to describe clinical and autonomic features of these girls.
Methods 10 girls with CDKL5mutations and a diagnosis of Hanefeld variant have been
evaluated on axiological and clinical aspects. In all subjects an evaluation of the
autonomic system was performed using the Neuroscope.
Results Common features were gaze avoidance, repetitive head movements and hand
stereotypies. The autonomic evaluation disclosed eight cases with the Forceful breather
cardiorespiratory phenotype and two cases with the Apneustic breather phenotype.
received
November 13, 2011
accepted after revision
February 6, 2012
Copyright © 2012 by Thieme Medical
Publishers, Inc., 333 Seventh Avenue,
New York, NY 10001, USA.
Tel: +1(212) 584-4662.
DOI http://dx.doi.org/
10.1055/s-0032-1308856.
ISSN 0174-304X.
Original Article 37
Th
is
 d
oc
um
en
t w
as
 d
ow
nl
oa
de
d 
fo
r p
er
so
na
l u
se
 o
nl
y.
 U
na
ut
ho
riz
ed
 d
ist
rib
ut
io
n 
is 
st
ric
tly
 p
ro
hi
bi
te
d.
Introduction
Rett syndrome (RTT) is a neuro-developmental disorder
almost exclusively affecting females, characterized by a broad
clinical spectrum. After the first identification of the gene in
19991MeCP2mutations are now identified in 90 to 95% of the
cases with classic RTT. In this form, after a period of appar-
ently normal development, patients show developmental
delay and loss of acquired skills such as purposeful hand
use and communication, a deceleration of head growth, and
appearance of stereotypic handmovements, ataxia/dyspraxia
and insufficient growth. Diagnostic criteria10,19 and several
RTT variants9 have subsequently been described, including
Zappella variant (preserved speech variant), characterized by
the recovery of some degree of speech,22 the congenital
variant (recognized since birth and often caused by FOXG1
mutation),3 and the “early onset seizure variant̶ or Hanefeld
variant.4,11
In 1984, Hanefeld described a girl with infantile spasms,
whose onset was within the first years of life; this girl only
subsequently disclosed symptoms of classic RTT with pro-
gressive drug-resistant epilepsy. In 2003, the Hanefeld variant
was associated with the cyclin dependent kinase-like 5 gene
(CDKL5), previously known as serine/threonine kinase 9
(STK9) and the first CDKL5 mutations were found in two girls
with a West syndrome clinical picture (infantile spasms,
hypsarrhythmia and severe mental retardation).15
CDKL5 is a putative serine/threonine kinase of unknown
function, expressed in several cell lines and tissues in early
developmental stages. CDKL5 is located in the cell nucleus
suggesting a gene regulation function. It has been observed
that MeCP2 and CDKL5 gene mutations lead to similar
phenotypes, and thereby it was postulated that they both
could be involved in the same signaling pathway. Since it has
been demonstrated that MeCP2 is subjected to phosphoryla-
tion and that CDKL5 has a kinase-domain, it seems possible
that MeCP2 is directly phosphorylated by CDKL5. Alterna-
tively, CDKL5 might phosphorylate a third intermediate
protein that could dephosphorylate MeCP2.
The clinical features identified in the patients reported in
literature15,17,21,24,25 are mostly of atypical RTT, myoclonic
encephalopathy, or epilepsy and mental retardation or au-
tism. Almost all patients show seizures during their lives with
a median age of onset of 2 months. The seizure pattern is
mainly characterized by infantile spasms, myoclonic jerks,
generalized tonic-clonic seizures, tonic seizures and, to a
lesser extent, absences and complex partial seizures. The
majority of cases is resistant to drug therapy. The EEG pattern
reported is also variable including a hypsarrythmic pattern,
focal or multifocal activity, diffuse high-voltage sharp waves,
and generalized theta rhythms.
The aim of the present study is to describe the clinical and
autonomic features of 10 RTT girls with Hanefeld variant and
CDKL5 gene mutation.
Materials/Subjects
We selected 10 patients with characteristics of atypical RTT
(Hanefeld variant) and CDKL5 mutations: 8 of them selected
from 119 cases referred to the Rett Centre at Versilia Hospital
(Lido di Camaiore, Tuscany) from October 2006 to Decem-
ber 2009; the other two froma population of 115 RTT patients
referred to the Swedish Rett Center (Sweden).
Hanefeld variant in the Italian sample was 8.4%, in the
Swedish 5.3%.
All cases with CDKL5 are female, the mean age is 7.7 years
(range 2 to 13).
Clinical and genetic features are reported in ►Tables 1
and 2.
Methods
The diagnosis of Hanefeld variant was based on established
clinical criteria.4 All subjects had been investigated by molec-
ular analysis of MeCP2 or CDKL5 gene. In our sample of
Hanefeld patients, all subjects had a CDKL5 mutation.
Our patients were evaluated clinically using the Interna-
tional Scoring System (ISS).16 Their cardiorespiratory pheno-
type was investigated with the Neuroscope (Medifit
Instruments Ltd, London, UK).12,14
Clinical Score
ISS consists of 21 items regarding the typical characteristics of
RTT, divided in five subscales: Growth and Development,
Muscolo-Skeletal appearance, Movement, Mental-Cortical
and Brainstem-Autonomic. Each item score ranges from 2
to 0 as follows: 2, severe abnormality; 1, mild abnormality; 0,
no abnormality.
Neuroscope
Autonomic and cardiorespiratory function indexes were re-
corded non-invasively and synchronouslywith EEG and video
over a 1-hour period. The autonomic parameters included:
cardiac vagal tone, heart rate, transcutanoeus blood gases,
and respiratory patterns. Following analysis of the recording
each patient was assigned to a specific cardiorespiratory
phenotype according to her respiratory dysrhythmia.
Conclusions The clinical picture remains within the RTT spectrum but some symp-
toms are more pronounced in addition to the very early onset of seizures. The
cardiorespiratory phenotype was dominated by Forceful breathers, while Feeble
breathers were not found, differently from the general Rett population, suggesting
a specific behavioral and cardiorespiratory phenotype of the RTT the Hanefeld variant.
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Thirteen abnormal, awake breathing rhythms have been
identified in the RTT population and categorised into Feeble,
Forceful, and Apneustic types of breathing. The RTT popula-
tion can be subdivided into these three groups of breathing
types. They constitute three unique cardiorespiratory phe-
notypes with different levels of blood gases, autonomic tone,
physical features, clinical complications and idiosyncratic
responses to drugs. Rational approaches to clinical manage-
ment are different and unique for each phenotype.13
Results
The clinical and autonomic characteristics of our sample are
summarized in ►Table 1.
All cases are female, the mean age is 7.7 years (range 2
to 13).
All subjects had an identified mutation in the CDKL5 gene
(N71D, I72N, R175S, R178W, E364X, R55fsX74, N314fsX349,
D618Efs620X, deletion of exons 7–8, deletion of exons 1–10).
The mutations observed can be divided into the following
groups: missense (4 cases), frameshift (3 cases), nonsense
(1 case), deletion (2 cases). At birth the head circumference
(HC) of 9 patients was within the normal range, in 1 case at
the 95th centile (gestational diabetes was diagnosed during
pregnancy).
The head growth was normal in 8 cases while 2 cases
presented acquired microcephaly. In the first year all patients
showed a delay in developmental milestones: among them
8 patients presented generalized hypotonia, with antigravi-
tary activity, whereas 2 had a normal muscular tone and they
acquired antigravitary, crawling and locomotion, but they
showed an ataxic gait. At the last evaluation, 6 patients had an
ataxic but unaided gait, while the others were unable to walk
(►Table 2). All patients had mental retardation, correspond-
ing to 1 and 2 in ISS; speech was absent in all patients. Some
kind of alterations of the visual system (nystagmus, squint,
myopia, hyperopia) were found in 8 of 10 cases.
From the behavioral point of view, common features were
mood disorders, gaze avoidance and hand stereotypies
(hand-mouthing, hand-washing, hand-clapping, often ob-
served in combination in the same subject); in addition, in
5 cases, repetitive head movements were noted. Self injury
behavior was rarely present in our sample. All subjects had
early onset epilepsy: with seizure onset in 3 cases in the first
month, in 3 cases the second month, in 3 cases, the fourth
month and in 1 case the sixth month. Mean age at seizure
onset was 2 months. Seizures at onset were predominantly
generalized tonic-clonic, infantile spasms, clonic seizures (in
two cases multifocal and in another case involving lower
limbs synchronously). After the first year of age, the seizures
evolved into infantile spasms, generalized tonic-clonic, partial
seizures and, in one case, tonic-adversive. According to Bahi-
Buisson5 we subdivided our patients into three categories on
the basis of the antiepileptic drug response: 4 patients were
drug resistant, 4 had partially controlled seizures (frequency
once in a month to once in a year) the other 2 were seizure
free at least from one year. The interictal EEG pattern showed
diffuse spike and wave activity, predominantly over the
fronto-temporal/centro-temporal areas in 3 cases and on
the occipital area in 1 case; 4 patients did not show significant
epileptic activity on the EEG.
Cerebral MRI was normal in 5 cases or showed only non-
specific abnormalities such as a mild increase of lateral
ventricle size and periencephalic spaces around the fronto-
temporal regions in 4 cases, and in another, mild asymmetry
of the occipital horns (►Table 1).
The Sleep-Wake Rhythm (SWR) in RTT patients showed
irregularity in the time of waking up and of falling asleep at
night and also profound daytime sleep by comparison with
normal children of the same age. Abnormalities in the SWR
are considered to be due to abnormalities of the serotonin
(5HT) neuronswhichdevelop in early infancybefore 4months
and also in late infancy around eight months and suggest
involvement of these neurons in these disorders.20,23
In the anamnestic datas sleep had been an important
problem from an early age in all the patients. In the first
4 months of life they all had sleeping problems. There were
severe derangements in the sleep-awake rhythm, they could
be awake for several days and nights in periods and sleep day
and night in other periods. They had also been woken up at
night by seizures. Three patients had regular sleep-awake
cycles (1, 4, 6,►Table 2), one of them aged 2 years; the others,
from 4 to 10 years, continued to present sleep problems even
if milder than in the first months of life.
The cardiorespiratory phenotype was Forceful in 8 of
10 cases and Apneustic in 2 of 10.
No caseswith feeble breathing were present in our sample.
Cardiorespiratory dysrhythimia was present during 37.9% of
the one hour recording on an average. The most frequent
dysrhythimias were tachypnoea (11.7%), deep breathing (4%)
and breath-holding (3.25%); less common were Valsalva
maneuvers (0.97%) and apnoea (1.4%). The mean vagal tone
was 5.2, range 2.2 to 7.6 in the linear vagal scale (LVS) (normal
range: 6 to 19 LVS); the maximum vagal tone was 26.7, range
7 to 40.
The total score of the ISS varied frommild to severe (range
14 to 33), in contrast to the score, generally severe, found in
most patient with classic RTT. There was a wide variability of
the cognitive levels in the subjects: mental disability varied
from severe to moderate with acquired abilities as reading
and writing with alphabet tables.
Discussion
All patients in this study had the characteristics of atypical
RTT and this suggests that the CDKL5 molecular analysis
should be performed not only in all subjects with the clinical
suspicion of the Hanefeld variant but also in MeCP2 negative
cases. On the other hand, the first case described by Hane-
feld11 had aMeCP2 genemutation (personal communication)
which may occasionally result in this variant.
Furthermore, a Rett girlwith atypical RTT andmutations in
both genes (although in the end theMeCP2was considered as
very rare polymorphism) has also been described7 suggesting
the possible coexistence of the CDKL5 mutation and the
MeCP2 mutation as well as a clinical overlap between the
Neuropediatrics Vol. 43 No. 1/2012
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two conditions. In cases of negativity in both genes, a further
investigation of FOXG1 gene could be useful, because epilepsy
may begin even earlier in the congenital variant.
The phenotype of the RTTof our samplewas dominated by
early onset epilepsy which is rare in girls with classic RTT due
toMeCP2mutations. This is themain distinctive feature of the
Hanefeld variant, reported in the literature. Our patients
present many clinical characteristics typical of RTT such as
delayed mental and motor development, loss of hand func-
tion, hand stereotypes and absence of speech; normal HC at
birth and subsequent deceleration of HC growthwas found in
only a minority of cases.
There was a great variability in the clinical picture: six
patients had mild ataxia, while the other four had severe
motor impairment with an inability towalk. The hand stereo-
types varied considerably in type and severity. In 5/10, the
presence of repetitive head movements was noted: among
them, 3 cases presented some kind of visual defect (squinting
in 2 cases and myopia in 1 case).
We found 4 types of seizures at presentation: generalized
tonic-clonic (1 case), clonic seizures (5 cases), partial tonic
seizures (1 case), “respiratory arrest” seizure (1 case) and
infantile spasms (2 cases). At the time of the clinical assess-
ment, therewas a great variability in the type of seizureswith
generalized tonic-clonic, infantile spasms, partial seizures
and atonic seizures in contrast to that suggested by other
authors who described patients with CDKL5 mutations as
having myoclonic encephalopathy syndromes.6
A characteristic electroencephalographic pattern was not
seen. Therewere diffuse unspecific abnormalities only in two
patients; six patients had epileptic discharges (five bilateral
and one multifocal) and two were normal. Archer et al.
reported that temporal or fronto-temporal activity was the
most common and could suggest a focal pathology, in agree-
ment with experimental studies showing that the highest
CDKL5 expression is reached in the first postnatal days in the
neocortex, the piriform cortex, and in the medial temporal
lobe structures.2
Most CDKL5 patients (9 of 10) were in politherapy, unlike
classic RTT where seizures were usually treated in mono-
therapy with good results.
Differently from other reports18 the patients in our study
showed symptoms of dysautonomia such as cold hands or
feet, constipation, diurnal dysrythmia and breathing dysryth-
mia such as hyperventilation, breath holding and Valsalva
maneuvers.
No cases with feeble breathing were found; the most
frequent type of respiratory dysrythmia was Forceful (8 of
10) while two cases were Apneustic breathers.
CDKL5 molecular analysis showed several kinds of muta-
tions. Three cases with “missense”mutations (all localized in
the catalytic domain of the CDKL5 protein) did not show a
mild phenotype in contrast to previous reports.8,24 In these
cases the range of ISSwas broader (14 to 33) if comparedwith
other classes of mutations; in addition, some autistic traits
like gaze avoidance and impairment in social interactionwere
also very evident. The case with the “non sense” mutation
had a severe ISS, comparable with the higher range of the
missense mutations. The “frameshift” mutations are in gen-
eral known to lead to a loss of function of the CDKL5 protein;
lack of functional CDKL5 protein is reported to cause severe
Infantile Spasm syndrome X linked (ISSX).24
In our sample the ISS in patientswith frameshiftmutations
is in the range of mild-moderate severity (14 to 17); among
themwe want to report one case with neuromotor delay, but
ability towalk at 6 years and good seizure control (started at 1
month). The same range of severity (of the moderate degree)
characterized all the caseswith the deletion type of mutation.
These data are not sufficient to draw firm conclusions but
could represent a contribution to definite genotype-pheno-
type correlations.
Conclusions
As MeCP2 gene mutations are not synonymous with Rett
syndrome so CDKL5 gene mutations are not synonymous
with the early-onset seizures variant. The term “Hanefeld
variant” should be reserved for patients with clinical features
of Rett syndrome, with epileptic encephalopathy before
6 months of age, regardless the presence of genetic abnor-
malities (mutations in MeCP2 or CDKL5 or both) or even in
their absence.
In patients with CDKL5 mutations, seizures are not always
intractable and cognitive levels are highly variable.
There is a possible relationship with the Forceful and
Apneustic cardiorespiratory phenotype.
Clinically, gaze avoidance and repetitive head movements
were common in addition to the typical RTT signs.
We believe this studywill contribute to delineate a specific
behavioral and cardiorespiratory phenotype of the RTT syn-
drome, the Hanefeld variant.
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